Corso di Laurea Magistrale in Farmacia

Size: px
Start display at page:

Download "Corso di Laurea Magistrale in Farmacia"

Transcription

1 Universita degli Studi di Milano Corso di Laurea Magistrale in Farmacia Tecnologia e Legislazione Farmaceutiche I - 9 CFU Prof. Andrea Gazzaniga Rilascio Modificato Orale Ritardato/Pulsatile Parte II

2 Swelling Controlled Release System (SCRS) film di EC e HPMC (75:25) nucleo (unità singole) contenente il farmaco ed un agente idrofilo rigonfiante (polivinilalcol) Morita R. et al., J. Control. Rel. 63, 297 (2000)

3 film semipermeabile di cellulosa acetato & nucleo (pellets) contenente il farmaco (paracetamolo) e un agente osmoattivo (NaCl) Schultz P. and Kleinebudde P., J. Control. Rel. 47, 181 (1997)

4 film di etilcellulosa (insolubile, permeabile) & nucleo (compresse o pellets) contenente il farmaco, agenti idrofili rigonfianti (Na carbossimetilcellulosa) e osmoattivi (NaCl, sorbitolo) Amidon G.L. and Leesman G.D., US Patent (1993)

5 film di etilcellulosa & nucleo (compresse) contenente il farmaco ed una miscela di acido citrico e sodio bicarbonato Kroegel I. and Bodmeier R., Int. J. Pharm. 187, 175 (1999)

6 Sistemi orali a rilascio ritardato/pulsante (delayed/pulsatile release) - sistemi réservoir - nucleo contenente il principio attivo - rivestimento ritardante il rilascio lacerazione per aumento della pressione interna aumento della permeabilità dissoluzione e/o erosione

7 Sigmoidal Release System (SRS) Narisawa S. et al., Pharm. Res. 11(1),111 (1994) aumento della permeabilità

8 Sistemi orali a rilascio ritardato/pulsante (delayed/pulsatile release) - sistemi réservoir - nucleo contenente il principio attivo - rivestimento ritardante il rilascio lacerazione per aumento della pressione interna aumento della permeabilità dissoluzione e/o erosione

9 Time-Clock System Pozzi F. et al., J. Control. Rel., 31, 99 (1994) Wax mixture spray-coating in rotating pan or fluid bed at C Core (tablet) Stage 1 - Erosion of the wax layer [surfactants/hydrophilic agents] Stage 2 - Rapid release of the active

10 Time-Clock System Pozzi F. et al., J. Control. Rel., 31, 99 (1994) Wax mixture spray-coating in rotating pan or fluid bed at C Core (tablet) Stage 1 - Erosion of the wax layer [surfactants/hydrophilic agents] Stage 2 - Rapid release of the active

11 Plasma concentration (ng/ml) Time-Clock System adapted from Pozzi F. et al., J. Control. Rel., 31, 99 (1994) conventional dosage form Time-Clock Time (min) Salbutamol plasma profiles following oral administration of conventional dosage form and TIME CLOCK

12 Eur. J. Pharm. Biopharm., 40 (4) (1994) Oral Chronotopic TM Drug Delivery Systems: Achievement of Time and / or Site Specificity Andrea Gazzaniga *,Maria Edvige Sangalli **,Ferdinando Giordano ** - * University of Milan, Institute for Pharmaceutical Chemistry, Milan, Italy - ** University of Pavia, Department of Pharmaceutical Chemistry, Pavia, Italy

13 Gazzaniga A. et al., Eur. J. Pharm. Biopharm. 40(4), 246 (1994) Hydrophilic swellable polymeric layer (HPMC, different viscosity grades) Stage 0 - Dissolution of gastric resistant film Stage 1 - Swelling/Erosion of polymeric layer Stage 2 - Rapid release of the active Drug-containing core [single/multiple unit]

14 amount released Chronotopic System The slow interaction polymer/fluid lead to the formation of a gel [glassy/rubbery] glassy drug particles rubbery time

15 amount released Chronotopic System Rapid or slow release depending on core characteristics glassy drug particles rubbery no release time

16 amount released Lag phase physical-chemical characteristics and coating level of the retarding polymer glassy drug particles rubbery lag phase no release time

17

18 How to prepare the retarding layer? spray-coating press-coating - polymers [high viscosity HPMC] never used before as coating agents. - technical obstacles to acceptable sprayability and reasonable processing time [hydroalcoholic dispersions/viscosity] - large-scale production implies use of special presses - difficult core centering with consequences on coating thickness uniformity

19 press-coating Methocel K100 LV

20 press-coating Methocel K100 LV limitations in the design flexibility owing to the large amount of coating needed

21 Adapted from Gazzaniga A. et al.- Eur.J. Pharm. Biopharm. 40(4), 246 (1994) press-coating Methocel K100 LV limitations in the design flexibility owing to the large amount of coating needed % released quite difficult to avoid the relatively and undesired long diffusion phase 0 time (min) Release profile of Verapamil.HCl from Methocel K100 LV press-coated systems with 150% weight gain mg/cm 2 coating polymer amount [tablet cores 60 mg]

22 Polymer 5 % W/W in Ethanol/Water mixture (84/6 w/w) spray-coating hydroalcoholic dispersions Methocel K15M Large scale production limitations due to the use of organic solvents

23 % released Chronotopic System Polymer 5 % W/W in Ethanol/Water mixture (84/6 w/w) spray-coating hydroalcoholic dispersions Methocel K15M Large scale production limitations due to the use of organic solvents tablet core 7,6 mg/cm ,2 mg/cm 2 22,8 mg/cm 2 30,4 mg/cm time (min) Release profiles of indomethacin from uncoated cores (4 mm diameter, 20 mg model drug) and systems spray-coated [rotating pan] with increasing amounts, mg/cm 2, of high viscosity HPMC - [hydro-alcoholic dispersion of Methocel K15M - 5% w/w] Adapted from Gazzaniga A. et al.- Eur.J. Pharm. Biopharm. 40(4), 246 (1994)

24 Adapted from Gazzaniga A. et al.- Eur.J. Pharm. Biopharm. 40(4), 246 (1994) Chronotopic System Polymer 5 % W/W in Ethanol/Water mixture (84/6 w/w) spray-coating hydroalcoholic dispersions Methocel K15M Large scale production limitations due to the use of organic solvents 300 Lag time (min) Applied polymer amount (mg/cm 2 ) Relationship between applied polymer amount and lag time for high viscosity HPMC spray-coated units [rotating pan, hydro-alcoholic dispersion of Methocel K15M- 5% w/w]

25 Spray coating with aqueous solutions of different HPMC viscosity grade Comparative evaluation of different HPMC viscosity grades, Methocel E5, E50 and K4M, in terms of process feasibility and performances as coating agents in aqueous solution unsolved issue how to switch to aqueous solvents? systematic study to select the most convenient HPMC aqueous coating systems

26 Spray coating with aqueous solutions of different HPMC viscosity grade M.E. Sangalli et al., Eur. J. Pharm. Sci. 22, 469 (2004) SEM photomicrographs of cross-sectioned systems coated with Methocel E5 (top), E50 (middle) and K4M (bottom) aqueous solutions at 16, 8 and 2% w/v, respectively (magnification 47x)

27 drug released (%) Spray coating with aqueous solutions of different HPMC viscosity grade M.E. Sangalli et al., Eur. J. Pharm. Sci. 22, 469 (2004) uncoated Methocel E5 Methocel E50 Methocel K4M 0 time (min) Release profiles obtained from uncoated cores and systems coated (w.g. 20%) with Methocel E5, E50 and K4M aqueous solutions at 16, 8 and 2% w/v, respectively

28 Spray coating with aqueous solutions of different HPMC viscosity grade finally Methocel E50 was selected for further studies since it affords the best balance among: -process time necessary for spray-coating -ability to delay drug release -final dimensions of the coated units -possibility of finely tuning the lag phase duration

29 Spray coating with aqueous solutions of Methocel E 50 A. Gazzaniga et al., STP Pharma Sci., 5, 83 (1995) fine tuning of lag time 100 % released core w.g. 22% w.g. 35% w.g. 50% w.g. 58% w.g. 73% w.g. 92% w.g. 115% w.g. 142% time (min) Release profiles of a tracer substance from uncoated cores (6.7 mm diameter, 180 mg weight, 2.3% methyl-4-hydroxybenzoate ) and cores coated with increasing amount of low viscosity HPMC (Methocel E50)

30 Spray coating with aqueous solutions of Methocel E 50 A. Gazzaniga et al., STP Pharma Sci., 5, 83 (1995) 210 Lag time (min) weight gain (%) 140 Relationship between weight gain and lag time for low viscosity HPMC (Methocel E50)-coated units (fluid bed).

31 Spray coating with aqueous solutions of Methocel E 50 A. Gazzaniga et al., STP Pharma Sci., 5, 83 (1995) 1.2 thickness (mm) weight gain (%) Relationship between weight gain and layer thickness for Methocel E50 caoted-units.

32 Spray coating with aqueous solutions of Methocel E 50 M.E. Sangalli et al., Eur. J. Pharm. Sci. 22, 469 (2004) % released 100 % released ph=1.5 time (min) ph=11.5 time (min) % released ph=7.5 time (min) Release profiles of acetaminophen obtained from Methocel E50-coated systems at different ph (weight gain: 20% - coating thickness 277 µm).

33 Spray coating with aqueous solutions of Methocel E 50 M.E. Sangalli et al., Eur. J. Pharm. Sci. 22, 469 (2004) 120 Lag timet 10 % (min) ionic strength-independent lag phase in the physiological range ionic strength t 10% as a function of the medium ionic strength for Methocel E50-coated systems (weight gain 20%, coating thickness 277 µm) - bars represent s.d.

34 Spray coating with aqueous solutions of Methocel E 50 M.E. Sangalli et al., Eur. J. Pharm. Sci. 22, 469 (2004) 120 Lag timet 10 % (min) ionic strength-independent lag phase in the physiological range ionic strength t 10% as a function of the medium ionic strength for Methocel E50-coated systems (weight gain 20%, coating thickness 277 µm) - bars represent s.d.

35 there was still room for improvement in process time spray-coating top spray fluid bed equipment tangential spray-coating powder layering rotor insert progressive decrease in process time

36 Tablets coated by spray-coating, top-spray fluid bed (thickness 475 µm, amount 49 mg/cm 2 ) Tablets coated by spray-coating, rotary tangential fluid bed (thickness 375 µm, amount 48 mg/cm 2 ) Tablets coated by powder layering, rotary tangential fluid bed (thickness 1020 µm, amount 48 mg/cm 2 ) 60 Lag time (min) <2 hours 13 hours 6 hours layer thickness ~ 450 µm, ~ 50 mg/cm 2 ) Weight gain (%) progressive decrease in process time

37 pellets large units design flexibility

38 Chronotopic System in vivo study on Antipyrine-containing units Model drug: Disintegrating core: Retarding layer: Spraying equipment: Volunteers: Sampling Antipyrine (50 mg) 6 mm, 158 mg Methocel E50 (thickness 325, 575 and 1020 µm) Fluid bed (Uniglatt, Glatt GmbH) 4 healthy male (age 36-45, weight 70-80Kg) Antipyrine was quantified in saliva by HPLC saliva and blood concentrations of Antipyrine are known to be consistent

39 Adapted from Sangalli M.E. et al., J. Control. Release 73, 103 (2001) HPMC coated units drug released (%) F F25 F50 F100 time (h) In vitro release profiles of antipyrine from uncoated cores (formulation F) and units coated with different amounts of HPMC (formulations F25, F50 and F100, coating thickness 325, 575 and 1020 µm); paddle, SIF, C, 100 rpm, mean of 6 replicates.

40 Adapted from Sangalli M.E. et al., J. Control. Release 73, 103 (2001) 1.8 saliva concentration (µg/ml) HPMC coated units saliva concentration (µg/ml) time (h) F F25 F50 F time (h) Average antipyrine saliva levels after oral administration of uncoated cores (formulation F) and units coated with differing amounts of HPMC (formulations F25, F50 and F100, coating thickness 325, 575 and 1020 µm).

41 Adapted from Sangalli M.E. et al., J. Control. Release 73, 103 (2001) Relationship between in vivo t 10% (time to 10% C max ) and coating thickness for formulations F25, F50 and F100 [coating thickness 325, 575 and 1020 µm] HPMC coated units in vivo lag time T 10% (min) y = 0,2812x - 58,195 R 2 = 0,9993 coating thickness (µm)

42 Adapted from Sangalli M.E. et al., J. Control. Release 73, 103 (2001) HPMC coated units 4 in vivo lag time T 10% (hours) 2 0 in vitro lag time T 10% (hours) Relationship between in vivo and in vitro lag time for systems coated with Methocel E50 up to 325, 575 and 1020 µm layer thickness.

POLYOX. Application Data. Formulation of POLYOX ER Matrices for a Highly Soluble Active APPLICATIONS DATA SUMMARY INTRODUCTION POLYOX - 1 -

POLYOX. Application Data. Formulation of POLYOX ER Matrices for a Highly Soluble Active APPLICATIONS DATA SUMMARY INTRODUCTION POLYOX - 1 - POLYOX Application Data Water Soluble Resins Formulation of POLYOX ER Matrices for a Highly Soluble Active APPLICATIONS DATA SUMMARY POLYOX, water soluble resins (WSR), can be used as an alternative to

More information

POLYOX. Application Data

POLYOX. Application Data POLYOX Application Data Water Soluble Resins The Influence of In Vitro Dissolution Method on the Release of a Highly Water Soluble Drug from Polyethylene Oxide and Hypromellose Hydrophilic Extended Release

More information

High Performance Dry Binding with CELNY-SSL Super Fine Powder

High Performance Dry Binding with CELNY-SSL Super Fine Powder CELNY TM hydroxypropyl cellulose for nutraceutical & food use NOTE #: APPLICATION: CELNY-SSL-SFP-1 Direct Compression/ ODT Formulation High Performance Dry Binding with CELNY-SSL Super Fine Powder APPLICATION

More information

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release March 2012 N. Passerini, B. Albertini, L.Rodriguez Department of Pharmaceutical Sciences, University of Bologna C.

More information

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance Dr Amina Faham (Dow), Dr Liz Meehan (AstraZeneca) ExcipientFest, Amsterdam NL June 24, 2014 What do you understand

More information

European Continuing Education College

European Continuing Education College Design and Development of Conventional and Modified Release Oral Drug Delivery Systems Three Day Intensive Course for Managers, Scientists and Technicians with the Emphasis on the Principles of Oral Drug

More information

Mostly, for a conventional dosage form the dosing i ntervals of the drug are much less than the drug half life leads to numerous limitations.

Mostly, for a conventional dosage form the dosing i ntervals of the drug are much less than the drug half life leads to numerous limitations. CHAPTER 5: SUMMARY AND CONCLUSION 5.1. SUMMARY AND CONCLUSION: Major challenge to controlled/sustained release drug deli very system is to uphold the drug delivery system at exacti ng site for extensive

More information

Generic Drug Formulations. with. and. Kollidon SR

Generic Drug Formulations. with. and. Kollidon SR Generic Drug Formulations with Kollicoat SR 3 D and Kollidon SR Contents I. Kollicoat SR 3 D Coating 1.1 Theophylline sustained-release pellets 1.2 Theophylline sustained-release pellets (drug-layering

More information

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms Author: Brian D. Wilson Background Recently, orally-dispersible dosage forms,

More information

Scuffing Measurement Methodology and Improved Film Coating Systems

Scuffing Measurement Methodology and Improved Film Coating Systems OPADRY II Application Data High Performance Film Coating System Scuffing Measurement Methodology and Improved Film Coating Systems PURPOSE Scuffing is a term used to describe coated tablet defects consisting

More information

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2.

Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2. PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty Ingredients ashland.com PTR-95 Page 1 of 5 Utility of Polyplasdone as a Tablet Binder Quyen Schwing, Marvin Davis, Divya Tewari, Thomas Dürig Ashland

More information

Dissolution Rate Enhancement of Fenofibrate Using Liquisolid Tablet Technique. Part II: Evaluation of In Vitro Dissolution Profile Comparison Methods.

Dissolution Rate Enhancement of Fenofibrate Using Liquisolid Tablet Technique. Part II: Evaluation of In Vitro Dissolution Profile Comparison Methods. Latin American Journal of Pharmacy (formerly Acta Farmacéutica Bonaerense) Lat. Am. J. Pharm. 28 (4): 538-43 (2009) Original Article Received: March 1, 2009 Accepted: April 9, 2009 Dissolution Rate Enhancement

More information

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250-0774

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250-0774 Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250- (RESEARC ARTICLE) QUALIFICATION OF EQUIPMENT: SAIZONER MIXER GRANULATOR, COMPRESSION MACINE AND COATING PAN * J. Vinod and A. Chenthilnathan Department of

More information

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION I. For Calcium Acetate Drug Products Table I.1 Submission Summary * Drug Product Name Strength(s)

More information

Techniques of Tablet Coating: Concepts and Advancements: A Comprehensive Review.

Techniques of Tablet Coating: Concepts and Advancements: A Comprehensive Review. e-issn: 2320-1215 RESEARCH AND REVIEWS: JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Techniques of Tablet Coating: Concepts and Advancements: A Comprehensive Review. Aalok Basu, Anjan De* and Suddhasattya

More information

TABLET REFORMULATION CASE STUDY. Executive Summary

TABLET REFORMULATION CASE STUDY. Executive Summary TABLET REFORMULATION Executive Summary A large European pharmaceutical company contracted Aptuit to reformulate a tablet with existing dosage strengths of 25 mg and 50 mg. The client required smaller strengths

More information

EFFECT OF DIFFERENT BIOADHESIVE POLYMERS ON PERFORMANCE CHARACTERISTICS OF VAGINAL TABLETS

EFFECT OF DIFFERENT BIOADHESIVE POLYMERS ON PERFORMANCE CHARACTERISTICS OF VAGINAL TABLETS EFFECT OF DIFFERENT BIOADHESIVE POLYMERS ON PERFORMANCE CHARACTERISTICS OF VAGINAL TABLETS Tambwekar K. R., Gunjan, Vermani K., Kandarapu R., Zaneveld L. J. D., and Garg S. National Institute of Pharmaceutical

More information

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion.

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion. Quality control of tablets Dissolution It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion. To ensure that the preparation comply with product

More information

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin)

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin) AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin) Description AMBERLITE IRP64 [1] resin is an insoluble, weakly acidic, hydrogen form, cation exchange resin supplied as a dry,

More information

Generic drugs are copies of innovator drug products

Generic drugs are copies of innovator drug products dx.doi.org/10.14227/dt190412p51 In Vitro Equivalence Studies of Generic Metformin Hydrochloride Tablets and Propranolol Hydrochloride Tablets Under Biowaiver Conditions in Lagos State, Nigeria e-mail:

More information

Katarzyna Małolepsza-Jarmołowska

Katarzyna Małolepsza-Jarmołowska EFFECT OF A POLYVINYL ALCOHOL AND SELECTED AUXILIARY SUBSTANCES ON THE PROPERTIES OF THERMOSENSITIVE HYDROPHILIC GELS CONTAINING LACTIC ACID COMPLEXED WITH CHITOSAN Katarzyna Małolepsza-Jarmołowska Chair

More information

Evaluating the Effects of Tablet Characteristics on Enteric Tablet Coating in the Novel Supercell TM Coater

Evaluating the Effects of Tablet Characteristics on Enteric Tablet Coating in the Novel Supercell TM Coater Evaluating the Effects of Tablet Characteristics on Enteric Tablet Coating in the Novel Supercell TM Coater 1. Abstract A Birkmire and K Walter Niro Pharma Systems, Columbia, MD USA In the pharmaceutical

More information

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create.

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create. GMP Services Solutions for Clinical Sample Manufacturing 1 EUDRAGIT Products 2 Technical Support 3 Formulation Development Proof of Concept 4 5 GMP Services 6 Advanced Drug Delivery Evonik. Power to create.

More information

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Formulation and evaluation of intragastric buoyant tablets of amoxicillin trihydrate

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Formulation and evaluation of intragastric buoyant tablets of amoxicillin trihydrate INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Formulation and evaluation of intragastric buoyant tablets of amoxicillin trihydrate A. Kotwal * and A.K. Pathak Department of Pharmacy, Barkatullah University,

More information

Quality by Design for ANDAs: An Example for Modified Release Dosage Forms

Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Introduction to the Example This is an example pharmaceutical development report illustrating how ANDA applicants can move toward

More information

Influence of the Changed USP Specifications on Disintegration Test Performance

Influence of the Changed USP Specifications on Disintegration Test Performance dx.doi.org/10.14227/dt170110p6 Influence of the Changed USP Specifications on Disintegration Test Performance e-mail: Raimar@ualberta.ca Katja Schmid 1 and Raimar Löbenberg 2 * 1 Department of Pharmacy

More information

AMBERLITE IRP69 Pharmaceutical Grade Cation Exchange Resin (Sodium Polystyrene Sulfonate USP)

AMBERLITE IRP69 Pharmaceutical Grade Cation Exchange Resin (Sodium Polystyrene Sulfonate USP) AMBERLITE IRP69 Pharmaceutical Grade Cation Exchange Resin (Sodium Polystyrene Sulfonate USP) Description AMBERLITE IRP69 [1] resin is an insoluble, strongly acidic, sodium form cation exchange resin supplied

More information

The potential impact of concomitant alcohol consumption

The potential impact of concomitant alcohol consumption dx.doi.org/10.14227/dt210114p11 Effect of Alcohol on Drug Release Kinetics from HPMC-Based Matrix Tablets Using Model Drugs e-mail: prof_avachat@yahoo.com Amelia M. Avachat* and Dinesh S. Nandare Department

More information

2.3 QUALITY OVERALL SUMMARY Sakura Tablet

2.3 QUALITY OVERALL SUMMARY Sakura Tablet English Mock QOS P2_Final_June08 MODULE 2: COMMON TECHNICAL DOCUMENT SUMMARIES Generic name: Amokinol 2.3 QUALITY OVERALL SUMMARY Sakura Tablet 1 English Mock QOS P2 Final TABLE OF CONTENTS Page Table

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)

More information

RESOURCE Q, 1 ml and 6 ml RESOURCE S, 1 ml and 6 ml

RESOURCE Q, 1 ml and 6 ml RESOURCE S, 1 ml and 6 ml GE Healthcare Life Sciences Instructions 71-7146-00 AI Ion Exchange Columns RESOURCE Q, 1 ml and 6 ml RESOURCE S, 1 ml and 6 ml Introduction RESOURCE Q and S are pre-packed columns for separating biomolecules

More information

Solid dosage forms testing: Disintegration test and tablet friability and hardness

Solid dosage forms testing: Disintegration test and tablet friability and hardness Specialized Laboratory for Drug production (N111049) Instructions Solid dosage forms testing: Disintegration test and tablet friability and hardness Tutor: Ing. Jiří Petrů Study program: Drug synthesis

More information

Comparative Assessment of the Quality Control Measurements of Multisource Ofloxacin Tablets Marketed in Nigeria

Comparative Assessment of the Quality Control Measurements of Multisource Ofloxacin Tablets Marketed in Nigeria dx.doi.org/10.14227/dt170210p20 Comparative Assessment of the Quality Control Measurements of Multisource Ofloxacin Tablets Marketed in Nigeria e-mail: jdjide@yahoo.com Sunday O. Awofisayo 1, *, Oladoja

More information

PREPARATION AND EVALUATION OF STARCH PHOSPHATE- A NEW MODIFIED STARCH AS A DISINTEGRANT IN TABLET FORMULATIONS

PREPARATION AND EVALUATION OF STARCH PHOSPHATE- A NEW MODIFIED STARCH AS A DISINTEGRANT IN TABLET FORMULATIONS Int. J. Chem. Sci.: 9(2), 2011, 889-899 Int. J. Chem. Sci.: ISSN 9(1), 0972-768X 2011, 1-11 www.sadgurupublications.com PREPARATIN AND EVALUATIN F STARCH PHSPHATE- A NEW MDIFIED STARCH AS A DISINTEGRANT

More information

International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com. Int. Res J Pharm. App Sci.

International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com. Int. Res J Pharm. App Sci. International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(4):1-16 Research Article Process Validation of Benazepril HCl

More information

Lovis 2000 M/ME. Microviscometer. ::: Viscometry at its best

Lovis 2000 M/ME. Microviscometer. ::: Viscometry at its best Lovis 2000 M/ME Microviscometer ::: Viscometry at its best Lovis 2000 M/ME is a rolling ball viscometer which unites an established measuring principle (Höppler, DIN 53015 and ISO 12058) with innovative

More information

Overview of Dissolution for BA/BE

Overview of Dissolution for BA/BE Biopharmaceutics Classification System based on Solubility/Permeability Biowaivers for BCS I Drugs Discussion of BCS III Drugs Models establishing in vivo-in vitro Correlations (IVIVC Levels A-C) 1 Biopharmaceutics

More information

Effect of Filler Type on the Stability of Polyethylene Oxide in a Hydrophilic Matrix Tablet

Effect of Filler Type on the Stability of Polyethylene Oxide in a Hydrophilic Matrix Tablet Effect of Filler Type on the Stability of Polyethylene Oxide in a Hydrophilic Matrix Tablet Jennifer L Hote-Gaston (jlhote@dow.com) and Dave Wallick The Dow Chemical Company, Dow Wolff Cellulosics, Larkin

More information

High Performance Dry Binding with HPC-SSL Super Fine Powder

High Performance Dry Binding with HPC-SSL Super Fine Powder NOTE #: Application: DC-ODT-2 Direct Compression/ ODT Formulation High Performance Dry Binding with HPC-SSL Super Fine Powder Application note Introduction (Super Fine Powder), a highly compressible grade

More information

REVIEW: IN-VITRO DRUG RELEASE CHARACTERIZATION MODELS Gautam Singhvi, Mahaveer Singh

REVIEW: IN-VITRO DRUG RELEASE CHARACTERIZATION MODELS Gautam Singhvi, Mahaveer Singh REVIEW: IN-VITRO DRUG RELEASE CHARACTERIZATION MODELS Gautam Singhvi, Mahaveer Singh Address for Correspondence Birla Institute of Technology and Science, Pilani Rajasthan 333 031 Email:singhvigautam@gmail.com

More information

EUDRAGIT E 100, EUDRAGIT E PO and

EUDRAGIT E 100, EUDRAGIT E PO and Technical Information EUDRAGIT E 100, and Specification and Test Methods Ph. Eur. USP/NF JPE Basic Butylated Methacrylate Copolymer Amino Methacrylate Copolymer - NF Aminoalkyl Methacrylate Copolymer E

More information

ACQUA PELLE WHAT IS ACQUA PELLE. instant hydration. novel texture. skin balance

ACQUA PELLE WHAT IS ACQUA PELLE. instant hydration. novel texture. skin balance FLUID SKIN BALANCING TECHNOLOGY WHAT IS ACQUA PELLE ACQUA PELLE 1. Liquid hydrogel 2. Electrolyte activated skin film + texture modifier 3. Pourable polymeric associative thickener 4. Salt activated +

More information

High Performance Thin Layer Chromatographic Method for Estimation of Cefprozil in Tablet Dosage Form

High Performance Thin Layer Chromatographic Method for Estimation of Cefprozil in Tablet Dosage Form ISSN: 0973-4945; CODEN ECJHAO E- Chemistry http://www.e-journals.net Vol. 5, No.3, pp. 427-430, July 2008 High Performance Thin Layer Chromatographic Method for Estimation of Cefprozil in Tablet Dosage

More information

The Story of Magnesium Stearate as a Powder and a Tablet Lubricant

The Story of Magnesium Stearate as a Powder and a Tablet Lubricant The Story of Magnesium Stearate as a Powder and a Tablet Lubricant Presented by Doug Lugge Director, API Development and Engineering Mallinckrodt What Are Customers Looking for in Selecting Pharmaceutical

More information

- KOBAYASHI ZEIN DP -

- KOBAYASHI ZEIN DP - Zein is a major component of corn proteins, called a prolamine soluble in aqueous ethanol. Zein is extracted from gluten meal separated under corn starch production. The acquisition of deodorized and decolourised

More information

An Immediate Release, Pearlescent, Film Coating System from Colorcon

An Immediate Release, Pearlescent, Film Coating System from Colorcon OPADRY fx Product Information Special Effects Film Coating Systems An Immediate Release, Pearlescent, Film Coating System from Colorcon A distinctive product appearance offers many benefits to the producers

More information

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com Research Article ISSN: 2349 4492 Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page: www.ajrbps.com IMPROVEMENT OF SOLUBILITY OF OMEPRAZOLE MAGNESIUM BY SOLID DISPERSION

More information

Modeling and Simulation of Complex Multiphase Flows in the Pharmaceutical Industry

Modeling and Simulation of Complex Multiphase Flows in the Pharmaceutical Industry SIMNET Days 2010 Februar 10, 2010 Modeling and Simulation of Complex Multiphase Flows in the Pharmaceutical Industry D. Suzzi a, G. Toschkoff a, S. Radl a,b, Th. Hörmann a, M. Schaffer a, D. Machold a,

More information

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application Coronary Stent System for Drug Application Yukon Choice DES + new catheter polymer-free DES Translumina - The polymer-free DES solution www.translumina.de A First Class Stent The YUKON Choice DES+ is the

More information

ACUSOL 810A Detergent Grade Rheology Modifier and Stabilizer

ACUSOL 810A Detergent Grade Rheology Modifier and Stabilizer ACUSOL 810A Detergent Grade Rheology Modifier and Stabilizer Description ACUSOL 810A is an Alkali Soluble acrylic polymer Emulsion (ASE). ACUSOL 810A can be directly incorporated into formulations without

More information

Colours in Pharmaceutical Products

Colours in Pharmaceutical Products Colour Management For Formulators 23 rd October 2013 Colours in Pharmaceutical Products Marcel Cimpan Senior Manager Customer and Technical Services Agenda Uses for colours in the Pharmaceutical industry

More information

http://www.propharmacia.pl 1

http://www.propharmacia.pl 1 Basic criteria for paediatric formulations Oral paediatric formulations problems, ideas and research Warszawa, Poland March 6, 2013 Prof. Dr. Jörg Breitkreutz Institute ofpharmaceutics and Biopharmaceutics

More information

Guidance for Industry

Guidance for Industry #171 Guidance for Industry Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles (This version of the guidance replaces

More information

The importance of normalisation when comparing tablet properties

The importance of normalisation when comparing tablet properties The importance of normalisation when comparing tablet properties Tablet quality definition The properties of a tablet, both during manufacturing and in vivo, are determined by the properties of the materials

More information

Regulatory Expectations of Presentation of Dissolution Data

Regulatory Expectations of Presentation of Dissolution Data Safeguarding public health Regulatory Expectations of Presentation of Dissolution Data David Darling Pharmaceutical Assessor Medicines and Healthcare products Regulatory Agency (MHRA), UK Content Why Use

More information

Capa Polyols. For excellent properties in crosslinked coatings. European Coating SHOW 2013 Nürnberg Pär Jörgensen Specialist

Capa Polyols. For excellent properties in crosslinked coatings. European Coating SHOW 2013 Nürnberg Pär Jörgensen Specialist Capa Polyols For excellent properties in crosslinked coatings European Coating SHOW 2013 Nürnberg Pär Jörgensen Specialist Outline Introduction of Perstorp Introduction of Caprolactones (Capa ) Use of

More information

Advancements in continuous tablet coating Jim Marjeram O Hara Technologies

Advancements in continuous tablet coating Jim Marjeram O Hara Technologies Advancements in continuous tablet coating Jim Marjeram O Hara Technologies 16 October 2008 0 Agenda Background on tablet coating Motivation for continuous processing Current continuous coating capability

More information

STARCH 1500. Application Data

STARCH 1500. Application Data STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone

More information

STUDY OF FREE-FILMS AND COATED TABLETS BASED ON HPMC AND MICROCRYSTALLINE CELLULOSE, AIMED FOR IMPROVE STABILITY OF MOISTURE-SENSITIVE DRUGS

STUDY OF FREE-FILMS AND COATED TABLETS BASED ON HPMC AND MICROCRYSTALLINE CELLULOSE, AIMED FOR IMPROVE STABILITY OF MOISTURE-SENSITIVE DRUGS Jundishapur Journal of Natural Pharmaceutical Products 2010; 5(1): 6-17 Jundishapur Journal of Natural Pharmaceutical Products STUDY OF FREE-FILMS AND COATED TABLETS BASED ON HPMC AND MICROCRYSTALLINE

More information

Tableting Punch Performance Can Be Improved With Precision Coatings

Tableting Punch Performance Can Be Improved With Precision Coatings Tableting Punch Performance Can Be Improved With Precision Coatings by Arnold H. Deutchman, Ph. D. Director of Research and Development (614) 873-4529 X 114 adeutchman@beamalloy.net Mr. Dale C. Natoli

More information

Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011

Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 1 Outline : Definition Harmonized general chapter USP 34

More information

SUCRALOSE. White to off-white, practically odourless crystalline powder

SUCRALOSE. White to off-white, practically odourless crystalline powder SUCRALOSE Prepared at the 41st JECFA (1993), published in FNP 52 Add 2 (1993). Metals and arsenic specifications revised at the 63rd JECFA (2004). An ADI of 0-15 mg/kg bw was established at the 37th JECFA

More information

EXIGENCIA DE ESTUDIOS DE BIOEQUIVALENCIA A TRAVÉS DE METODOS IN VITRO

EXIGENCIA DE ESTUDIOS DE BIOEQUIVALENCIA A TRAVÉS DE METODOS IN VITRO EXIGENCIA DE ESTUDIOS DE BIOEQUIVALENCIA A TRAVÉS DE METODOS IN VITRO Q.F. ALEXIS ACEITUNO, PhD Jefe Subdepto. Biofarmacia & Bioequivalencia Agencia Nacional de Medicamentos Instituto de Salud Pública

More information

Bioequivalence Testing, using the Dissolution Profile

Bioequivalence Testing, using the Dissolution Profile Determining Similarity of Products- F 2 Criterion and Variability of Dissolution Test Vivian Gray V. A. Gray Consulting Dissolution Workshop December 10, 2010 Bioequivalence Testing, using the Dissolution

More information

Introduction to Enteris BioPharma

Introduction to Enteris BioPharma Introduction to Enteris BioPharma Enteris BioPharma Intelligent Solutions for Oral Drug Delivery Privately held, New Jersey based biotech company Owned solely by Victory Park Capital, a large Chicago based

More information

CypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT)

CypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT) TM CASE STUDY CypExpress 3A4 Catalyzed Conversion of to Shuvendu Das, 1 Enrique Martez, 2 and Mani Subramanian 1 1 Center for Biocatalysis and Bioprocessg, University of Iowa 2 Oxford Biomedical Research,

More information

Superdisintegrants: introduction to chemistry and performance

Superdisintegrants: introduction to chemistry and performance Superdisintegrants: introduction to chemistry and performance MCC Starch Lactose Inhalation Superdisintegrants Summary The superdisintegrantsprimojel (sodium starch glycolate) and Primellose (croscarmellose

More information

Workshop B Control Strategy

Workshop B Control Strategy ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation

More information

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25.

Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25. Dissolution Testing Analytik,Methodenentwicklung, Bioäquivalenz SAQ Olten, 25. Januar 2006 Dr. H. Potthast (h.potthast@bfarm.de) 1 2 Basis for Biowaiver Applications/Decisions Note for Guidance on the

More information

The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets

The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OPADRY II Application Data High Performance Film Coating System The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OBJECTIVES

More information

THE PHARMACEUTICAL INDUSTRY

THE PHARMACEUTICAL INDUSTRY TE PARMACEUTICAL INDUSTRY The pharmaceutical industry in New Zealand takes the active ingredients of drugs (which are imported from overseas) and converts them into a form that can easily be given to a

More information

Laser Printing of Polymeric Materials

Laser Printing of Polymeric Materials Laser Printing of Polymeric Materials Mr Soumya Banerjee & Prof. David IanWimpenny Rapid Prototyping & Manufacturing Group Faculty of Computing Sciences & Engineering, DeMontfort University, Leicester,UK

More information

UNIVERSITY OF PARMA INTERDEPARTMENTAL CENTRE FOR INNOVATION IN HEALTH PRODUCTS, BIOPHARMANET-TEC

UNIVERSITY OF PARMA INTERDEPARTMENTAL CENTRE FOR INNOVATION IN HEALTH PRODUCTS, BIOPHARMANET-TEC UNIVERSITY OF PARMA INTERDEPARTMENTAL CENTRE FOR INNOVATION IN HEALTH PRODUCTS, BIOPHARMANET-TEC RULES FOR THE USE OF THE CENTER EQUIPMENTS ACQUIRED WITHIN THE AGREEMENT BETWEEN THE UNIVERSITY OF PARMA

More information

FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE

FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE e-issn 2249 7706 print-issn 2249 7714 International Journal of Advanced Pharmaceutics www.ijapjournal.com FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF

More information

Development of validated RP- HPLC method for estimation of rivaroxaban in pharmaceutical formulation

Development of validated RP- HPLC method for estimation of rivaroxaban in pharmaceutical formulation IJPAR Vol.4 Issue 4 Oct Dec - 2015 Journal Home page: ISSN: 2320-2831 Research Article Open Access Development of validated RP- HPLC method for estimation of rivaroxaban in pharmaceutical formulation V.

More information

Extended release Improving formulation of HPMC matrices

Extended release Improving formulation of HPMC matrices Article reprinted from the September 2008 issue of Extended release Improving formulation of PMC matrices Don Farrall/Getty Images Image supplied by Colorcon Modulation of drug release from hydrophilic

More information

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.1, pp 49-55, Jan-Mar 2012 Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval

More information

Alharith Hassan. Q 10 Method of Shelf-life estimation. Methods of Chemical stabilisation 11/20/2015

Alharith Hassan. Q 10 Method of Shelf-life estimation. Methods of Chemical stabilisation 11/20/2015 Q 10 Method of Shelf-life estimation Q 10 approach is an old concept that could be useful for estimating the shelf-life at room temperature of products recommended for cold storage. Calculations are based

More information

Functional Evaluation of Moisture Barrier Systems D. Tewari, W. W. Harcum, T. Dürig and B. Kinsey

Functional Evaluation of Moisture Barrier Systems D. Tewari, W. W. Harcum, T. Dürig and B. Kinsey PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty Ingredients ashland.com PTR-071-1 (Supersedes PTR-071) Functional Evaluation of Moisture Barrier Systems D. Tewari, W. W. Harcum, T. Dürig and B. Kinsey

More information

Compilation of individual product-specific guidance on demonstration of bioequivalence

Compilation of individual product-specific guidance on demonstration of bioequivalence 17 December 2014 EMA/CHMP/736403/2014 Committee for Medicinal Products for Human Use (CHMP) Compilation of individual product-specific guidance on demonstration of bioequivalence Initial batch of individual

More information

Sublingual drug delivery system

Sublingual drug delivery system Sublingual drug delivery system List of contents 1. Sublingual tablets 2. Fast-disintegrating sublingual tablets 3. Bioadhesive sublingual tablet 4. Thin film drug delivery 5. Lipid matrix sublingual tablet

More information

C-100E Strong Acid Cation Exchange Resin (For use in water softening applications)

C-100E Strong Acid Cation Exchange Resin (For use in water softening applications) ION EXCHANGE RESINS C-1E Strong Acid Cation Exchange Resin (For use in water softening applications) Lenntech info@lenntech.com www.lenntech.com Tel. +31-15-61.9. Fax. +31-15-61.6.89 Technical Data PRODUCT

More information

As published in PIM International

As published in PIM International As published in PIM International www.pim-international.com 64 Powder Injection Moulding International September 2012 Rapid prototyping of highperformance ceramics opens new opportunities for the CIM industry

More information

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES February 2013 RESTRICTED GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES DRAFT FOR COMMENT Should you have any comments on the attached text, please send these to Dr Sabine Kopp, Manager, Medicines

More information

Kolliphor Grades Emulsifier for topical pharmaceutical applications

Kolliphor Grades Emulsifier for topical pharmaceutical applications Technical Information January 2014 03_120610e-01/Page 1 of 6 WF-No. 125032 Kolliphor Grades Emulsifier for topical pharmaceutical applications = Registered trademark of BASF 03_120610e-01 January 2014

More information

Opadry II / Opadry / Opaglos 2

Opadry II / Opadry / Opaglos 2 Opadry II / Opadry / Opaglos 2 Application Data High Productivity Film Coating / Complete Film Coating System / High Gloss Film Coating Systems Modern Tablet Film Coatings and Influence on Ease of Swallowing

More information

QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse. Adrian Funke

QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse. Adrian Funke QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse Adrian Funke Symposium der Fachgruppe Arzneimittelkontrolle / Pharmazeutische Analytik der DPhG Freiburg

More information

Permeability Study on the Coating Film Consisting of CA-398-10 NF/EP and CA- 320S NF/EP

Permeability Study on the Coating Film Consisting of CA-398-10 NF/EP and CA- 320S NF/EP Permeability Study on the Coating Film Consisting of CA-398-10 NF/EP and CA- 320S NF/EP Please note: This article is the original unedited version of the article that was featured in Drug Development &

More information

Chronotherapeutics and Chronotherapeutic Drug Delivery Systems

Chronotherapeutics and Chronotherapeutic Drug Delivery Systems Tropical Journal of Pharmaceutical Research, October 2009; 8 (5): 467-475 Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Review Article

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations U.S. Department of Health and Human Services Food and Drug Administration Center

More information

New Dissolution Method for Mesalamine Tablets and Capsules

New Dissolution Method for Mesalamine Tablets and Capsules dx.doi.org/10.14227/dt150308p7 New Dissolution Method for Mesalamine Tablets and Capsules Monica C. Chuong 1,3, J. Mark Christensen 2, and James W. Ayres 2 1 Department of Pharmaceutical Sciences, Massachusetts

More information

Strategy for Functional Material Development in FUJIFILM

Strategy for Functional Material Development in FUJIFILM 証券コード 4901 Strategy for Functional Material Development in FUJIFILM - Global competency strategy for business innovation in Functional Material Industry - Sep. 24, 2013 FUJIFILM Corporation Development

More information

INSULIN PRODUCTS. Jack DeRuiter

INSULIN PRODUCTS. Jack DeRuiter INSULIN PRODUCTS Jack DeRuiter The number and types of insulin preparations available in the United States is constantly changing, thus students should refer to recent drug resources for a current list

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Dissolution Testing of Immediate Release Solid Oral Dosage Forms U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research

More information

GYAN VIHAR UNIVERSITY

GYAN VIHAR UNIVERSITY 7. In Vitro Skin Permeation Studies In vitro skin permeation studies were performed on a Franz diffusion cell with an effective diffusional area of 0.636 cm2 and 4 ml of receiver chamber capacity using

More information

RESEARCH ARTICLE PREPARATION AND EVALUATION OF LEVOFLOXACIN HEMIHYDRATES FLOATING TABLETS

RESEARCH ARTICLE PREPARATION AND EVALUATION OF LEVOFLOXACIN HEMIHYDRATES FLOATING TABLETS JOUN OF U IVY SCH SCH TIC PPTION N VUTION OF VOFOXCIN HMIHYTS FOTIN TBTS YK Y.B* 1, Sai kishore.v 2, TejaKrishna.M 1, Prasada ao. K.V.S. 1 1. ahul institute of Pharmaceutical Sciences and esearch,chirala.

More information

Draft agreed by Pharmacokinetics Working Party January 2011. Adoption by CHMP for release for consultation 17 February 2011

Draft agreed by Pharmacokinetics Working Party January 2011. Adoption by CHMP for release for consultation 17 February 2011 17 November 2011 EMA/CHMP/600958/2010/Corr.* Committee of Medicines for Human Use (CHMP) Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 Rev.1): Presentation of

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: AN OVERVIEW Gupta Surbhi 1 *, Saini Seema 1, Singh Gurpreet

More information

Double Rotary Tablet Press. (Pharma Press Gmp Model) Instrumented Tablet Press (Pharma Press-II)

Double Rotary Tablet Press. (Pharma Press Gmp Model) Instrumented Tablet Press (Pharma Press-II) Press (Pharma Mega Press Gmp Model) Press (Pharma Mega Press Gmp Model) CE Approved Double Rotary Tablet Press (Pharma Press Gmp Model) Rotary Tablet Press GMP Model Press (Pharma Mega Press Gmp Model)

More information